Sweco AB (NASDAQ:SWEC-B) released its interim report for the period January to September 2026 on October 29, 2026, reporting third-quarter net sales of SEK 7,606 million and an EBITA margin of 10.3 per cent.

Key Highlights

  • Q3 net sales: SEK 7,606 million, up from SEK 7,138 million in the prior-year quarter, representing 7 per cent growth and 2 per cent organic growth adjusted for calendar effects.
  • Q3 EBITA: SEK 786 million (prior year: SEK 702 million), with a margin of 10.3 per cent (prior year: 9.8 per cent), up 10 per cent adjusted for calendar effects.
  • Q3 earnings per share: SEK 1.44, compared with SEK 1.18 in the same quarter of the prior year; diluted EPS was SEK 1.44 (prior year: SEK 1.17).
  • Nine-month net sales: SEK 24,508 million (prior year: SEK 23,038 million), with EBITA of SEK 2,519 million and a margin of 10.3 per cent.
  • Net debt/EBITDA: Decreased to 0.8x for the nine-month period, compared with 0.9x in the prior-year period.
  • Acquisitions: Four businesses completed during Q3, including STEIN Ingenieure, Sitowise Sverige AB, All Soil Assistance, and Technocon; nine acquisitions closed in total year-to-date across four business areas.
  • Framework agreement: Sweco was awarded a SEK 500 million framework agreement for high-security facilities for Specialfastigheter in Sweden.

Sweco's Third-Quarter 2026 Financial Results and Acquisition Activity

According to the filing, Sweco reported what it described as its "strongest third quarter results to date," with net sales reaching SEK 7,606 million compared with SEK 7,138 million in the prior-year period. The company disclosed that organic growth amounted to 2 per cent after adjustment for calendar effects. EBITA rose to SEK 786 million from SEK 702 million, with the EBITA margin improving to 10.3 per cent from 9.8 per cent. EBIT increased to SEK 752 million (prior year: SEK 643 million), representing a margin of 9.9 per cent, and profit for the quarter reached SEK 521 million, up from SEK 424 million.

The filing attributed the improvement primarily to "a strong billing ratio and higher average fees." Sweden, Norway, and Finland were cited as the main contributors to EBITA improvement in the quarter. The filing noted that Sweco Belgium delivered strong margins, while Sweco Netherlands, UK, and Germany and Central Europe continued to improve profits. In Denmark, EBITA and net sales were lower, which the filing attributed to "reduced activity in the Danish pharmaceutical sector," while the Danish business maintained what the filing described as a strong margin.

For the nine-month period January to September 2026, the filing reported net sales of SEK 24,508 million (prior year: SEK 23,038 million), EBITA of SEK 2,519 million (prior year: SEK 2,352 million), and earnings per share of SEK 4.74 (prior year: SEK 4.34). Net debt increased to SEK 3,160 million (prior year: SEK 3,124 million), while net debt/EBITDA decreased to 0.8x from 0.9x. During the quarter, the company completed four acquisitions and disclosed the completion of a fifth, Stendess in Belgium, in early October. The filing also noted a major framework agreement with Belgian national railway company NMBS/SNCB and the appointment as sole consultant to Aalborg Forsyning in Denmark.

What Was Disclosed

Sweco filed an interim report covering the third quarter and first nine months of 2026, disclosing net sales, EBITA, EBIT, profit, earnings per share, net debt figures, and details of four acquisitions completed in Q3 plus one in early October.